Recent Updates
Recently added Catalysts
ICU Positive Sentiment Score: 75/100

SeaStar Medical to Present at the Maxim Group Virtual Healthcare Conference Hosted by M-Vest on June 21, 2023

Key Takeaway: SeaStar Medical Holding Corporation, a developer of medical devices targeted at hyperinflammation, announced that CEO Eric Schlorff will present at the Maxim Group Virtual Healthcare Conference on June 21, 2023. The presentation is set to offer insights into the company's innovative therapies aimed at mitigating inflammation's harmful effects on vital organs. Interested participants can register for the event via the SeaStar Medical website. The conference seeks to connect investors with emerging growth companies for information exchange and market trend analysis.

Market Sentiment Analysis

POSITIVE FACTORS

  • SeaStar Medical is presenting at a prominent healthcare conference.
  • The conference allows for greater investor access and insights.
  • The company's innovations aim to provide life-saving solutions.

Full Press Release Details

DENVER, June 14, 2023 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces that Eric Schlorff, CEO, will present at the Maxim Group Virtual Healthcare Conference hosted by M-Vest on Wednesday, June 21 at 2:30 p.m. Eastern time (11:30 a.m. Pacific time). Mr. Schlorff’s discussion will be hosted by Maxim Group Executive Managing Director of Research Anthony V. Vendetti.
Registration information to become a M-Vest member for access to the live and archived presentation webcast will be posted to Events & Presentations section of the SeaStar Medical website.
M-Vest is a division of Maxim Group LLC that serves to allow investors to access investment opportunities online and to provide a digital community built for issuers, investors, and thought leaders to share information. The platform provides insights on current market trends through presentations from innovative emerging growth companies and commentary from industry thought leaders via live events and Q&A.
About SeaStar Medical
SeaStar Medical is a medical technology company that is redefining how extracorporeal therapies may reduce the consequences of excessive inflammation on vital organs. SeaStar Medical’s novel technologies rely on science and innovation to provide life-saving solutions to critically ill patients. The Company is developing and commercializing cell-directed extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. For more information visit www.seastarmedical.com or visit us on LinkedIn or Twitter.
LHA Investor Relations

Tags

SeaStar Medical Holding Corp
medical device company
Maxim Group Virtual Healthcare

Frequently Asked Questions

When will SeaStar Medical present at the Maxim Group Conference?

SeaStar Medical will present on June 21 at 2:30 p.m. Eastern time.

Who is hosting the discussion with Eric Schlorff?

The discussion will be hosted by Anthony V. Vendetti from Maxim Group.

How can I access the presentation webcast?

Registration information for the webcast will be available on SeaStar Medical's website.

What does SeaStar Medical focus on?

SeaStar Medical focuses on reducing hyperinflammation effects on vital organs.

What type of therapies is SeaStar Medical developing?

They are developing cell-directed extracorporeal therapies for critically ill patients.

Last updated: Jun 14, 2023